Alliance Supports Medication Reconciliation

Published Online: Thursday, December 1, 2005

Siemens Medical Solutions and RxHub have entered into a strategic partnership to provide clinicians with easy access to detailed, up-to-date outpatient medication history. The information can be reviewed and incorporated into a patient's medication reconciliation within the acute care setting.

The agreement calls for Siemens to offer its large base of hospital and health system customers access to RxHub's MEDS. The MEDS service provides access to the drug benefit eligibility status of >150 million covered individuals. In line with the Joint Commission on Accreditation of Healthcare Organizations' patient-safety initiatives, Siemens will provide its acute care customers with a leading-edge solution for querying the database of contracted pharmacy benefit managers and payers to determine what medications a patient has been and/or is currently taking. The arrangement should significantly improve reliability in medication reconciliation.

"One of the major causes of medication errors in the hospital setting is [the] lack of complete patient information at the point of care," said David McLean, chief executive officer of RxHub.

Tom Miller, president of the health care IT division of Siemens Medical Solutions, commented, "As we continue to deploy innovative patientsafety solutions and add leading clinical content partners to our portfolio, this alliance enables Siemens to immediately deliver critical patientspecific medication history information to clinicians at the appropriate point of care."

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues